Table 3 The meta-analysis results of patients’ secondary efficacy outcomes after treatment
Outcome indexs | No.Trials (Patients) | SMD (95% CI) | I2 (%) | PEgger |
|---|---|---|---|---|
Oxygenation index (PaO2/FiO2) | 26 (1824) | 2.04 [1.62, 2.46] | 93 | < 0.001 |
Respiratory rate | 15 (1117) | -1.08 [−1.29, − 0.88] | 60 | 0.001 |
Serum inflammatory factor (TNF-α) | 8 (600) | -3.06 [−4.34, −1.78] | 97 | < 0.001 |
Serum inflammatory factor (IL-1β) | 2 (137) | -3.49 [−4.64, − 2.34] | 78 | – |
Serum inflammatory factor (IL-6) | 7 (523) | -2.39 [−3.34, −1.45] | 94 | 0.002 |
Serum inflammatory factor (IL-8) | 4 (286) | -2.43 [−3.86, −1.00] | 95 | – |